Engene Holdings Common Etf Analysis

ENGN Etf  USD 8.69  0.08  0.91%   
enGene Holdings Common is undervalued with Real Value of 11.89 and Target Price of 35.5. The main objective of EnGene Holdings etf analysis is to determine its intrinsic value, which is an estimate of what enGene Holdings Common is worth, separate from its market price. There are two main types of EnGene Etf analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic stability of enGene Holdings Common. On the other hand, technical analysis, focuses on the price and volume data of EnGene Etf to identify patterns and trends that may indicate its future price movements.
The EnGene Holdings etf is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in enGene Holdings Common. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in price.

EnGene Etf Analysis Notes

The fund retains about 97.03% of assets under management (AUM) in fixed income securities. To learn more about enGene Holdings Common call JD Esq at 514 332 4888 or check out https://www.engene.com.

enGene Holdings Common Investment Alerts

EnGene Holdings appears to be risky and price may revert if volatility continues
Net Loss for the year was (99.92 M) with profit before overhead, payroll, taxes, and interest of 0.
EnGene Holdings generates negative cash flow from operations
Over 83.0% of the company shares are held by institutions such as insurance companies
Latest headline from simplywall.st: Recent uptick might appease enGene Holdings Inc. institutional owners after losing 4.2 percent over the past year
The fund retains about 97.03% of its assets under management (AUM) in fixed income securities

EnGene Holdings Thematic Classifications

In addition to having EnGene Holdings etf in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products Idea
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

EnGene Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 440.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate EnGene Holdings's market, we take the total number of its shares issued and multiply it by EnGene Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

enGene Holdings Common has return on total asset (ROA) of (0.2207) % which means that it has lost $0.2207 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2306) %, meaning that it created substantial loss on money invested by shareholders. EnGene Holdings' management efficiency ratios could be used to measure how well EnGene Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
At enGene Holdings Common, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Beta
(0.76)
Return On Assets
(0.22)
Return On Equity
(1.23)

Technical Drivers

As of the 3rd of December, EnGene Holdings shows the semi deviation of 4.23, and Risk Adjusted Performance of 0.0826. enGene Holdings Common technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the entity's future prices.

enGene Holdings Common Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. EnGene Holdings middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for enGene Holdings Common. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

enGene Holdings Common Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EnGene Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on EnGene Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EnGene Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over two weeks ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 5997 shares of EnGene Holdings at 6.5436 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over a month ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 561797 shares of EnGene Holdings at 8.9 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over a month ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 800 shares of EnGene Holdings at 6.5981 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over a month ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 11844 shares of EnGene Holdings at 6.546 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over a month ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 5997 shares of EnGene Holdings at 6.5436 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over two months ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 10153 shares of EnGene Holdings at 6.3722 subject to Rule 16b-3
 
Forbion Growth Opportunities Fund I Cooperatief U.a. over two months ago
Acquisition by Forbion Growth Opportunities Fund I Cooperatief U.a. of 341332 shares of EnGene Holdings at 6.338 subject to Rule 16b-3
 
Ronald Cooper over two months ago
Acquisition by Ronald Cooper of 10000 shares of EnGene Holdings at 5.7 subject to Rule 16b-3
 
Glickman Richard M over two months ago
Acquisition by Glickman Richard M of 4123 shares of EnGene Holdings at 0.88 subject to Rule 16b-3
 
Glickman Richard M over six months ago
Acquisition by Glickman Richard M of 120 shares of EnGene Holdings at 0.88 subject to Rule 16b-3
 
Glickman Richard M over six months ago
Acquisition by Glickman Richard M of 11189 shares of EnGene Holdings at 0.88 subject to Rule 16b-3
 
Forbion Capital Fund Iii Cooperatief U.a. over six months ago
Disposition of tradable shares by Forbion Capital Fund Iii Cooperatief U.a. of EnGene Holdings subject to Rule 16b-3

EnGene Holdings Predictive Daily Indicators

EnGene Holdings intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EnGene Holdings etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

EnGene Holdings Forecast Models

EnGene Holdings' time-series forecasting models are one of many EnGene Holdings' etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary EnGene Holdings' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About EnGene Etf Analysis

Etf analysis is the technique used by a trader or investor to examine and evaluate how EnGene Holdings prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling EnGene shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as EnGene Holdings. By using and applying EnGene Etf analysis, traders can create a robust methodology for identifying EnGene entry and exit points for their positions.
EnGene Holdings is entity of United States. It is traded as Etf on NASDAQ exchange.

Current EnGene Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. EnGene analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. EnGene analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
35.5Strong Buy8Odds
enGene Holdings Common current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most EnGene analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand EnGene stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of enGene Holdings Common, talking to its executives and customers, or listening to EnGene conference calls.
EnGene Analyst Advice Details

EnGene Etf Analysis Indicators

enGene Holdings Common etf analysis indicators help investors evaluate how EnGene Holdings etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading EnGene Holdings shares will generate the highest return on investment. By understating and applying EnGene Holdings etf analysis, traders can identify EnGene Holdings position entry and exit signals to maximize returns.
Begin Period Cash Flow20.4 M
Long Term Debt9.2 M
Common Stock Shares Outstanding23.2 M
Total Stockholder Equity72.5 M
Tax Provision17 K
Property Plant And Equipment Net589 K
Cash And Short Term Investments81.5 M
Cash81.5 M
Accounts Payable1.2 M
Net Debt-71.7 M
50 Day M A7.873
Total Current Liabilities5.3 M
Other Operating Expenses26.1 M
Non Current Assets Total1.5 M
Non Currrent Assets Other860 K
Stock Based Compensation3.5 M

Other Information on Investing in EnGene Etf

EnGene Holdings financial ratios help investors to determine whether EnGene Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EnGene with respect to the benefits of owning EnGene Holdings security.